Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas. Read more about Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas.
Acute hepatic porphyrias: Recommendations for evaluation and long-term management. Read more about Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Read more about Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.
Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. Read more about Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list.
Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Read more about Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection. Read more about The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Read more about Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Read more about Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Read more about Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Read more about Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
